KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
收藏DataCite Commons2026-02-11 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009158/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study will compare the ability of fosamprenavir 700 mg with ritonavir 100 mg twice a day
or lopinavir 400 mg with ritonavir 100 mg twice a day both combined with a fixed dose
combination tablet of abacavir 600 mg and lamivudine 300 mg once a day to suppress virus
levels of HIV to less than 400 copies/mL of blood. In addition we will study the safety and
tolerability of these compounds over the 48 week study period in patients naive to anti-HIV
therapy.
提供机构：
Vivli
创建时间：
2023-08-15
